Oncology
Daiichi Sankyo gears up for five ADC launches in 2026
On the sidelines of JPM, Daiichi-Sankyo US CEO Ken Keller told pharmaphorum about the company's big year and its long-term strategy in ADCs.
Digital
On digital health and the Rural Health Transformation Progra...
As reported in January this year, the United States Centers for Medicare & Medicaid Services (CMS) rolled out $10 billion in
R&D
Why the government’s latest funding push is critical to the ...
Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa
R&D
Navigating development in a complex molecule world
For decades, the pharmaceutical industry has relied on accelerated development and manufacturing timelines to bring new therapies to patients quickly.
Patients
Sponsored
7 Strategies for fixing pharma's outdated patient engagement...
The term 'patient centricity' has undergone a radical evolution over recent years.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
